US Stock MarketDetailed Quotes

NEO NeoGenomics

Watchlist
  • 14.660
  • +0.160+1.10%
Close Jan 23 16:00 ET
  • 14.660
  • 0.0000.00%
Post 20:01 ET
1.88BMarket Cap-24.03P/E (TTM)

NeoGenomics Key Stats

NeoGenomics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 173.062M--
--2024/Q4-- / 173.284M--
Nov 5, 20242024/Q3167.824M / 167.028M--
Jul 29, 20242024/Q2164.502M / 162.002M--
Apr 30, 20242024/Q1156.240M / 149.700M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 173.062M--
--2024/Q4-- / 173.284M--
Nov 5, 20242024/Q3167.824M / 167.028M--
Jul 29, 20242024/Q2164.502M / 162.002M--
Apr 30, 20242024/Q1156.240M / 149.700M--

Unlock Free Earnings Estimates

NeoGenomics Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Jan 23, 2025

Buy

  • Buy

    54.55%
  • Hold

    45.46%
  • Sell

    0.00%

Price Target

No Data